Assure Holdings Corp. (IONM)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -20.08 Million USD | 27.82% |
| 2022 | -27.82 Million USD | -1208.13% |
| 2021 | -2.12 Million USD | 86.87% |
| 2020 | -16.2 Million USD | -783.38% |
| 2019 | 2.37 Million USD | -49.92% |
| 2018 | 4.73 Million USD | 172.5% |
| 2017 | -6.53 Million USD | -11287.72% |
| 2016 | -57.35 Thousand USD | -102.87% |
| 2015 | -28.27 Thousand USD | 42.66% |
| 2014 | -49.3 Thousand USD | -23.01% |
| 2013 | -40.08 Thousand USD | 76.63% |
| 2012 | -171.52 Thousand USD | -175.7% |
| 2011 | -62.21 Thousand USD | 8.97% |
| 2010 | -68.34 Thousand USD | 22.87% |
| 2009 | -88.6 Thousand USD | -32.18% |
| 2008 | -67.03 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4.37 Million USD | 46.06% |
| 2024 Q2 | -1.38 Million USD | 68.29% |
| 2023 Q3 | -4.2 Million USD | 23.01% |
| 2023 FY | -20.08 Million USD | 27.82% |
| 2023 Q1 | -3.34 Million USD | 79.34% |
| 2023 Q2 | -5.46 Million USD | -63.4% |
| 2023 Q4 | -8.11 Million USD | -92.89% |
| 2022 Q2 | -6.45 Million USD | -64.27% |
| 2022 Q3 | -3.8 Million USD | 41.03% |
| 2022 Q4 | -16.18 Million USD | -325.45% |
| 2022 Q1 | -3.92 Million USD | -2211.29% |
| 2022 FY | -27.82 Million USD | -1208.13% |
| 2021 Q4 | 186 Thousand USD | -67.48% |
| 2021 Q2 | -1.46 Million USD | 3.62% |
| 2021 Q3 | 572 Thousand USD | 139.07% |
| 2021 FY | -2.12 Million USD | 86.87% |
| 2021 Q1 | -1.51 Million USD | -18.86% |
| 2020 Q2 | -13.91 Million USD | -7182.72% |
| 2020 Q4 | -1.27 Million USD | -55.1% |
| 2020 FY | -16.2 Million USD | -783.38% |
| 2020 Q1 | -191 Thousand USD | 97.89% |
| 2020 Q3 | -824 Thousand USD | 94.08% |
| 2019 Q3 | 4.59 Million USD | 0.46% |
| 2019 Q4 | -9.05 Million USD | -297.09% |
| 2019 FY | 2.37 Million USD | -49.92% |
| 2019 Q1 | 2.25 Million USD | 139.45% |
| 2019 Q2 | 4.57 Million USD | 102.64% |
| 2018 Q1 | 3.02 Million USD | 122.6% |
| 2018 FY | 4.73 Million USD | 172.5% |
| 2018 Q4 | -5.72 Million USD | -249.34% |
| 2018 Q3 | 3.83 Million USD | 6.47% |
| 2018 Q2 | 3.59 Million USD | 18.96% |
| 2017 Q3 | 2.09 Million USD | 3.25% |
| 2017 Q4 | -13.38 Million USD | -737.63% |
| 2017 Q1 | 2.72 Million USD | 11414.69% |
| 2017 FY | -6.53 Million USD | -11287.72% |
| 2017 Q2 | 2.03 Million USD | -25.34% |
| 2016 Q4 | -24.07 Thousand USD | -28.29% |
| 2016 Q1 | -4462.88 USD | 46.2% |
| 2016 FY | -57.35 Thousand USD | -102.87% |
| 2016 Q2 | -10.43 Thousand USD | -133.86% |
| 2016 Q3 | -18.76 Thousand USD | -79.78% |
| 2015 Q3 | -7728.12 USD | -27.63% |
| 2015 FY | -28.27 Thousand USD | 42.66% |
| 2015 Q1 | -7039.75 USD | 38.27% |
| 2015 Q2 | -6054.89 USD | 13.99% |
| 2015 Q4 | -8296.02 USD | -7.35% |
| 2014 FY | -49.3 Thousand USD | -23.01% |
| 2014 Q3 | -8060.53 USD | 62.94% |
| 2014 Q4 | -11.4 Thousand USD | -41.48% |
| 2014 Q1 | -9144.37 USD | 52.04% |
| 2014 Q2 | -21.74 Thousand USD | -137.84% |
| 2013 Q1 | -9106.10 USD | 79.56% |
| 2013 FY | -40.08 Thousand USD | 76.63% |
| 2013 Q4 | -19.06 Thousand USD | -333.87% |
| 2013 Q3 | -4394.23 USD | 41.38% |
| 2013 Q2 | -7496.01 USD | 17.68% |
| 2012 FY | -171.52 Thousand USD | -175.7% |
| 2012 Q1 | -41.47 Thousand USD | -1.29% |
| 2012 Q2 | -56.22 Thousand USD | -35.56% |
| 2012 Q3 | -26.82 Thousand USD | 52.29% |
| 2012 Q4 | -44.55 Thousand USD | -66.11% |
| 2011 Q4 | -40.95 Thousand USD | -319.78% |
| 2011 Q1 | -6341.12 USD | 73.93% |
| 2011 Q2 | -5968.90 USD | 5.87% |
| 2011 Q3 | -9755.23 USD | -63.43% |
| 2011 FY | -62.21 Thousand USD | 8.97% |
| 2010 Q3 | -21.72 Thousand USD | -156.44% |
| 2010 FY | -68.34 Thousand USD | 22.87% |
| 2010 Q4 | -24.32 Thousand USD | -11.96% |
| 2010 Q2 | -8471.68 USD | 38.64% |
| 2010 Q1 | -13.8 Thousand USD | 76.67% |
| 2009 FY | -88.6 Thousand USD | -32.18% |
| 2009 Q4 | -59.17 Thousand USD | -891.98% |
| 2009 Q3 | -5965.01 USD | 26.25% |
| 2009 Q2 | -8088.20 USD | 35.78% |
| 2009 Q1 | -12.59 Thousand USD | -2104.21% |
| 2008 FY | -67.03 Thousand USD | 0.0% |
| 2008 Q3 | -20.13 Thousand USD | 54.61% |
| 2008 Q2 | -44.35 Thousand USD | -1071.57% |
| 2008 Q1 | -3786.07 USD | 0.0% |
| 2008 Q4 | -571.38 USD | 97.16% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 103.964% |
| Addus HomeCare Corporation | 90.95 Million USD | 122.079% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 311.768% |
| Amedisys, Inc. | 156.39 Million USD | 112.841% |
| American Oncology Network, Inc. | -49.15 Million USD | 59.145% |
| Astrana Health, Inc. | 84.61 Million USD | 123.734% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 348.786% |
| IMAC Holdings, Inc. | -6.37 Million USD | -214.987% |
| biote Corp. | 28.65 Million USD | 170.077% |
| Cryo-Cell International, Inc. | -12.3 Million USD | -63.215% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 117.817% |
| COMPASS Pathways plc | -136.91 Million USD | 85.333% |
| DocGo Inc. | 15.05 Million USD | 233.391% |
| The Ensign Group, Inc. | 255.36 Million USD | 107.864% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 132.204% |
| InnovAge Holding Corp. | -23.18 Million USD | 13.365% |
| The Joint Corp. | -2.07 Million USD | -868.7% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 89.382% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | -27.88% |
| ModivCare Inc. | -139.94 Million USD | 85.65% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 47640.363% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | -134.79% |
| Option Care Health, Inc. | 314.59 Million USD | 106.383% |
| P3 Health Partners Inc. | -167.86 Million USD | 88.036% |
| P3 Health Partners Inc. | -167.86 Million USD | 88.036% |
| The Pennant Group, Inc. | 25.16 Million USD | 179.789% |
| Surgery Partners, Inc. | 328 Million USD | 106.123% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | -595.457% |
| Talkspace, Inc. | -23.2 Million USD | 13.473% |
| Talkspace, Inc. | -23.2 Million USD | 13.473% |
| The Oncology Institute, Inc. | -77.01 Million USD | 73.926% |
| The Oncology Institute, Inc. | -77.01 Million USD | 73.926% |